Methods for Enclosing and Analyzing a Cell in a Fluidic Device
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 12,661,647 | Methods for Enclosing and Analyzing a Cell in a Fluidic Device In force · High confidence | Cellanome. Inc. | In force | High confidence | ||
| Application 18/891,555 | Multiplex Cellular Assays for Screening and Quality Assessment of Engineered Cells Abandoned Abandoned Dec 12, 2025 | Cellanome, Inc. | Abandoned | Abandoned Dec 12, 2025 | ||
| Application 19/684,891 | Methods for Enclosing and Analyzing a Cell in a Fluidic Device Pending Not granted | Cellanome. Inc. | Pending | Not granted |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Cellanome, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.